Urovant Sciences Enters into Flexible Agreement for up to $100 Million Debt Financing with Hercules Capital
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Feb 22, 2019--Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercial…
